Lexology July 16, 2024
Portfolio Media. Inc. | 230 Park Avenue, 7th Floor | New York, NY 10169 | www.law360.com Phone: +1 646 783 7100 | Fax: +1 646 783 7161 | [email protected]
Health Regulators Likely To Tread Carefully Post-Chevron
By Theresa Schliep
Law360 (June 28, 2024, 9:37 PM EDT) — The demise of Chevron deference at the U.S. Supreme Court on Friday will likely encourage or fortify challenges to agency rulemaking on matters of health policy in the U.S., from Medicare reimbursement decisions to FDA rules on laboratory-developed tests.
The decision, representing a historic shift in power from regulators to the courts, also risks making the agencies that oversee health and medicine more cautious, potentially slowing action during public health emergencies and...
Today's Sponsors
Today's Sponsor